News >

Obesity Linked to Improved Outcomes in Men With Metastatic Melanoma

Jason Harris
Published: Thursday, Feb 22, 2018

Jennifer McQuade, MD

Jennifer McQuade, MD
Obese men treated with targeted or immune therapies for metastatic melanoma had a 47% reduced risk of death compared with men who had a normal BMI, according to results from a retrospective multicohort analysis published in The Lancet Oncology.1
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication